4. gada 2022. februāris: Indijā vēzim var būt nopietnas sociālas un ekonomiskas sekas, kas parasti izraisa ģimenes nabadzību un sabiedrības netaisnību. Šajā demogrāfiski jaunajā valstī ziņots par vēža saslimstības rādītājiem, kas pielāgoti vecumam, joprojām ir diezgan zemi. 1.3 miljardu iedzīvotāju populācijā katru gadu tiek atklāts nedaudz vairāk nekā 1 miljons jaunu vēža gadījumu. Vecuma koriģētā izteiksmē tas atspoguļo apmēram ceturto daļu no vīriešu un sieviešu saslimstības Rietumeiropā. No otras puses, vēzis bija atbildīgs par aptuveni 600000 700000–2012 XNUMX nāves gadījumu Indijā XNUMX. gadā.
Saskaņā ar IHME pētījuma Global Burden of Disease Study 2019 analīzi, aina nav īpaši atšķirīga visā pasaulē. 2019. gadā jaunu vēža gadījumu skaits pārsniedza 23 miljonus, salīdzinot ar 18.7 miljoniem 2010. gadā. 2019. gadā ar vēzi miruši 10 miljoni cilvēku, salīdzinot ar 8.29 miljoniem 2010. gadā. Šie rezultāti liecina par attiecīgi 20.9 procentu un 26.3 procentu pieaugumu. .
In both developing and developed countries, cancer is a leading cause of morbidity and mortality. The majority of the population in many low- and middle-income nations, including India, does not have access to a well-organized and well-regulated cancer care system. When a person is diagnosed with cancer, they are often forced to spend a lot of money on their own health. Such expenses can push entire families into poverty and, when paired with a lack of what are considered acceptable services, can jeopardize social stability. It can be easily said that cancer treatment in India is still in a nascent stage and huge development is required in this field.
There are two major problems cancer patients and their family members face when someone is diagnosed with cancer. One is, where will they get the best and most appropriate treatment, and two, how much money will be required for treatment? Second is the most important question, as the general population in India is still devoid of health insurance. We at CancerFax addresses both these problems. We help cancer patients find most appropriate and economical cancer treatment in India and abroad. CancerFax is working with more than 100 top cancer hospitals in 10 countries like Dana-Farber, Mayo Clinic, Boston Children’s Hospital, Sheba, Asan, Apollo, BLK, Artemis to name a few.
CAR T-Cell therapy is a breakthrough treatment for some kinds of lymphoma, leukemia and multiple myeloma. CancerFax helps patients enroll for CAR T-šūnu terapija treatment in the USA, Israel and China. Many patients who had previously relapsed blood tumors had no evidence of cancer after CAR T-Cell therapy. It has also aided in the rehabilitation of patients who have previously failed to respond to most traditional cancer therapies. There are more than 300 ongoing clinical trials in the world’s leading cancer centers on this therapy. CAR T-Cell therapy in India is available as clinical trials now. I hope it will be available for commercial treatment very soon.
